Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-12

FDA Approved: SODIUM NITROPRUSSIDE — Original Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved BE Pharmaceuticals Inc.'s original application for a generic sodium nitroprusside product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium nitroprusside (sodium nitroprusside)

Snippet

ORIG AP for SODIUM NITROPRUSSIDE (SODIUM NITROPRUSSIDE)